Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma.
about
The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinomars35301225 polymorphism in miR-34a promotes development of human colon cancer by deregulation of 3'UTR in E2F1 in Chinese population.E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway.Taurine upregulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma.Function analysis of rs9589207 polymorphism in miR-92a in gastric cancer.Molecular Pathogenesis of Hepatocellular Carcinoma.Hormonal control of the metabolic machinery of hepatocellular carcinoma.Novel Pathways of Endocrine Disruption through Pesticides Interference with Human Mineralocorticoid Receptors.Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.The selective mineralcorticoid receptor (MR) antagonist eplerenon prevents decompensation of liver cirrhosis.microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect.MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer.
P2860
Q33779972-012D59D6-A798-4BF9-BD53-79F839E8EF94Q37692620-05A0D222-3B53-4D1D-96A5-93F40FF5E52CQ37708206-DBBF15DE-B0EC-44E0-BBA3-ABABC15D5F1AQ38627909-56A09C2F-7545-475B-8AEA-0128B1A2C17AQ38825007-D5D70BA9-1B69-4CFA-91A4-5C283EEEF8FDQ41544729-8FDA64BB-1282-4B5B-9714-250E0CC48553Q41911845-120B7E71-B6AB-43B2-A4D5-13E412887BE2Q46259512-66FF6F82-D2DB-4022-B023-1C694685FB7DQ47096853-0BB7F5B3-1E97-4CA7-AFC6-D6349917F372Q47555775-BD492DF9-0863-45C0-98E1-29D112DAB2F0Q50042578-2D041377-03AC-4F6C-B3EC-2ECC2E98A913Q52570905-13B244A1-89CC-4488-9DDC-0F3BDCD9349FQ53181847-2BA8CDBE-E9C9-490C-8BCE-926E4FD2DC9FQ54112524-25BD3917-CBBD-4CF8-8150-F45239E52782
P2860
Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mineralocorticoid receptor sup ...... s in hepatocellular carcinoma.
@ast
Mineralocorticoid receptor sup ...... s in hepatocellular carcinoma.
@en
type
label
Mineralocorticoid receptor sup ...... s in hepatocellular carcinoma.
@ast
Mineralocorticoid receptor sup ...... s in hepatocellular carcinoma.
@en
prefLabel
Mineralocorticoid receptor sup ...... s in hepatocellular carcinoma.
@ast
Mineralocorticoid receptor sup ...... s in hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Mineralocorticoid receptor sup ...... s in hepatocellular carcinoma.
@en
P2093
Huizhen Nie
Jianren Gu
Ming-Xuan Feng
Qing-Zhen Cao
Wenxin Qin
Xiao-Mei Yang
P2860
P304
P356
10.1002/HEP.27940
P407
P577
2015-06-16T00:00:00Z